DRS250117C32000
- 1.30
- -0.10-7.14%
Leonardo DRS, Inc. Newsroom
BofA Securities Maintains Leonardo DRS, Inc.(DRS.US) With Hold Rating, Raises Target Price to $40
Truist Financial Maintains Leonardo DRS, Inc.(DRS.US) With Buy Rating, Maintains Target Price $36
BTIG Maintains Leonardo DRS, Inc.(DRS.US) With Buy Rating, Raises Target Price to $38
J.P. Morgan Maintains Leonardo DRS, Inc.(DRS.US) With Hold Rating, Raises Target Price to $32
Leonardo DRS Is Maintained at Neutral by JP Morgan
Baird Maintains Leonardo DRS, Inc.(DRS.US) With Buy Rating, Raises Target Price to $40
Truist Financial Maintains Leonardo DRS, Inc.(DRS.US) With Buy Rating, Raises Target Price to $36
Leonardo DRS Analyst Ratings
Baird Maintains Outperform on Leonardo DRS, Raises Price Target to $40
Morgan Stanley Maintains Leonardo DRS, Inc.(DRS.US) With Hold Rating, Raises Target Price to $34
Morgan Stanley Maintains Leonardo DRS, Inc.(DRS.US) With Hold Rating, Maintains Target Price $32
Baird Maintains Leonardo DRS, Inc.(DRS.US) With Buy Rating, Maintains Target Price $30
Truist Financial Maintains Leonardo DRS, Inc.(DRS.US) With Buy Rating, Raises Target Price to $32
Truist Financial Sticks to Its Buy Rating for Leonardo Drs (DRS)
Leonardo DRS Analyst Ratings
BofA Securities Downgrades Leonardo DRS, Inc.(DRS.US) to Hold Rating, Announces Target Price $30
BTIG Maintains Leonardo DRS, Inc.(DRS.US) With Buy Rating, Maintains Target Price $33
Leonardo DRS Analyst Ratings
BTIG Maintains Buy on Leonardo DRS, Raises Price Target to $33
BTIG Maintains Leonardo DRS, Inc.(DRS.US) With Buy Rating, Raises Target Price to $33